[Erythrocyte coagulating and fibrinolytic activity in chronic ischemic heart disease].
It is shown that the erythrocytes of patients suffering from chronic ischaemic heart disease have normal or increased procoagulant, decreased anticoagulant and fibrinolytic activity, i.e. they enhance the increased coagulating and decrease the fibrinolytic potential of plasma in this group of patients. Addition of syncumar to the combined treatment causes certain decrease of the erythrocyte hypercoagulation potential, though it still remains marked. The fibrinolytic activity of plasma and erythrocytes remains unchanged.
D000328:Adult; D000368:Aged; D001777:Blood Coagulation; D001778:Blood Coagulation Disorders / Q000503:physiopathology; D002908:Chronic Disease; D003327:Coronary Disease / Q000503:physiopathology*; D004903:Erythrocyte Aggregation; D004912:Erythrocytes / Q000502:physiology*; D005260:Female; D005342:Fibrinolysis; D006400:Hematocrit; D006801:Humans; D008297:Male; D008875:Middle Aged
Svertyvaiushchaia i fibrinoliticheskaia aktivnost' éritrotsitov u bol'nykh khronicheskoĭ ishemicheskoĭ bolezn'iu serdtsa.